EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Connexin 43 Deficiency Confers Resistance to Immunotherapy in Lung Cancer via Inhibition of the Cyclic GMP‐AMP Synthase–Stimulator of Interferon Genes Pathway

Yuan Zhang iD, Yu Gao iD, Jie Wang, Xiaoming Tan, Yusheng Liang, Weize Yu, Zihua Deng, Jingjing Zhou, Zu Ye, Guoqing Luo

Journal of Cellular and Molecular Medicine · 2024

DOI: 10.1111/jcmm.70211 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Yuan Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Qingyuan Hospital, Qingyuan People's Hospital, Guangzhou Medical University, Qingyuan, Guangdong, China. Hauptthemen laut MEDLINE: Connexin 43, Lung Neoplasms, Membrane Proteins, Carcinoma, Lewis Lung. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation for High-level Talents in Higher Education of Qingyuan People's Hospital, Foundation for Young Talents in Higher Education of Guangdong, China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune checkpoint inhibitors (ICIs), especially PD‐1 inhibitors, are among the first‐line therapeutic drugs for the treatment of advanced non‐small cell lung cancer (NSCLC). However, most patients are not sensitive to PD‐1 inhibitors, and prolonged exposure can lead to acquired resistance. Thus, it is urgent to elucidate the mechanism underlying the resistance of NSCLC to ICIs. Connexin 43 (Cx43) is a gap junction (GJ) protein that is important in therapeutic efficacy to ICIs. In this study, we observed that Cx43 in murine Lewis lung carcinoma (LLC) cells mediated cyclic GMP‐AMP (cGAMP) transfer to macrophages. Knockdown of Cx43 reduced T‐cell activation, leading to decreased sensitivity of LLC cells to anti‐PD‐1 therapy. The mechanism might be that knockdown of Cx43 in LLC cells promotes macrophages differentiation into pro‐tumour M2 type (TAM), thus activating the STING pathway in macrophages. These findings indicate that downregulation of Cx43 in LLC cells leads to immunotherapy resistance by negatively regulating the cGAS–STING pathway in macrophages. Therefore, Cx43/GJ‐mediated signal transmission between lung cancer cells and macrophages provides new insights for increasing immunotherapy sensitivity in NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Connexin 43Lung NeoplasmsMembrane ProteinsCarcinoma, Lewis LungMacrophagesImmunotherapySignal TransductionNucleotides, CyclicAnimalsMiceNucleotidyltransferasesMice, Inbred C57BLDrug Resistance, NeoplasmHumansCell Line, TumorImmune Checkpoint InhibitorsCarcinoma, Non-Small-Cell LungSTING ProteinCyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase

Stichwörter der Autor:innen

STINGcGAMPconnexin 43macrophage

Substanzen

Connexin 43Membrane ProteinsNucleotides, CyclicNucleotidyltransferasesImmune Checkpoint Inhibitorscyclic guanosine monophosphate-adenosine monophosphateSting1 protein, mouseSTING ProteincGAS protein, mouseCyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase

Autor:innen und Institutionen

  • Affiliated Qingyuan Hospital, Qingyuan People's Hospital, Guangzhou Medical University, Qingyuan, Guangdong, China.
  • Qingyuan Maternal and Child Healthcare Hospital, Qingyuan, Guangdong, China.
  • College of Pharmacy, Dali University, Dali, Yunnan, China.
  • Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.

ORCID-Profile: Yuan Zhang, Yu Gao

Förderung

  • Foundation for High-level Talents in Higher Education of Qingyuan People's Hospital
  • Foundation for Young Talents in Higher Education of Guangdong, China
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, Y., Gao, Y., Wang, J., Tan, X., Liang, Y., Yu, W., Deng, Z., Zhou, J., Ye, Z., & Luo, G. (2024). Connexin 43 Deficiency Confers Resistance to Immunotherapy in Lung Cancer via Inhibition of the Cyclic GMP‐AMP Synthase–Stimulator of Interferon Genes Pathway. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70211

Vancouver

Zhang Y, Gao Y, Wang J, Tan X, Liang Y, Yu W, et al. Connexin 43 Deficiency Confers Resistance to Immunotherapy in Lung Cancer via Inhibition of the Cyclic GMP‐AMP Synthase–Stimulator of Interferon Genes Pathway. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.70211

BibTeX
@article{Zhang2024,
  author = {Zhang, Yuan and Gao, Yu and Wang, Jie and Tan, Xiaoming and Liang, Yusheng and Yu, Weize and Deng, Zihua and Zhou, Jingjing and Ye, Zu and Luo, Guoqing},
  title = {Connexin 43 Deficiency Confers Resistance to Immunotherapy in Lung Cancer via Inhibition of the Cyclic GMP‐AMP Synthase–Stimulator of Interferon Genes Pathway},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  doi = {10.1111/jcmm.70211}
}
Kostenlos starten →